CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Investigation to Identify the Cause of an Observed Change in Mortality Risk Attributable to Ozone | Health Canada · CanPursue
Opportunities
Fit is part of the trial and paid plans.Closed

Investigation to Identify the Cause of an Observed Change in Mortality Risk Attributable to Ozone

Health Canada1000173351Federal
Find on CanadaBuysAdd to pipeline
Published
Jul 2, 2015
Respond by
Jul 16, 2015
Latest amendment
None

See how this opportunity fits your company

Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.

Create free account

Who won similar work

Create a free account to see past contracts like this one: who won and at what price.

Create free account

Description

NOTICE OF PROPOSED PROCUREMENT (NPP)

Solicitation #: 1000173351 Closing Date: July 16, 2015 Time: 2 p.m. EDT

This requirement is for the department of Health Canada.

Title: Investigation to Identify the Cause of an Observed Change in Mortality Risk Attributable to Ozone

Scope: Considerable research over the last 20 years has established a clear and significant link between ground ozone levels and adverse health effects, including asthma, heart attack, strokes, and death. Early research, largely consisting of cohort studies using case-crossover designs, linked these health effects to long-term exposure to ambient ozone. Continued efforts led to evidence of links between short-term exposure to ozone and several health markers, including myocardial infarction and ischemic stroke, cardiovascular and respiratory diseases, and mortality. Several meta-analyses have contributed to the evidence in support of a scientific link between ozone exposure and mortality, with additional work finding that there is no safe threshold level for individual exposure.

The first substantive results linking ozone to human health dealt largely with long-term exposures. This was due to two reasons: lack of suitable data, and lack of suitable analytical frameworks (including computational power). The invention and popularization of Generalized Additive Models (GAMs), and the development of computing resources sufficient to estimate them, provided sufficient structure to allow for the estimation of health risk due to acute exposure. Prior to 2003, most scientific work linking ozone and health effects dealt with long-term ambient exposure, rather than short-term acute effects.

Since 2000, there has been a tremendous amount of work published on the relationship between acute exposure to air pollution (AP) and a variety of health outcomes. These outcomes include mortality, ischemic stroke and any number of other diseases. The majority of these studies use time-series regression models, typically computed in the framework of Generalized Additive Model (GAM) or Generalized Linear Model (GLM). Additionally, most such studies use one contiguous time block for analysis, e.g., 1987—2000 (the NMMAPS database), or 2000—2005 (analysis of the heat wave of 2003). An exception to this rule has been the Air Health Indicator (AHI) project, which seeks to model time trends in the risk.

The AHI project has developed models for estimation of risk due to acute exposure to air pollutants, primarily ozone and PM2.5 in Canadian urban centers. The principal investigator of the present proposal has developed multi-year risk estimators and proposed a 7-year estimator for the AHI using a simulation study based on Canadian data. There was further shown to be no evidence for either an increasing or decreasing trend in NO2 adverse health effects on Canadian population using single-year estimators. Using the 7-year estimator, however, the AHI has recently detected a substantial decline in ozone’s impact on Canadian heart or lung (cardio-pulmonary, CP) related mortality risks for the warm season from April to September. The decline seems to be strongly related to season and cause of mortality, as no change was observed in the cold season risk or in mortality from other causes. Further studies on historical ozone concentrations, the CP mortalities, additional confounders (e.g., heart or lung related drug usage), and correlations between ozone and ozone precursors (NOx, VOCs), and meteorological variables (MET, temperature, humidity, sunlight) are therefore necessary to prove or disprove the apparent declining trend in ozone-CP mortality associations at regional and national levels for warm season.

Objectives of the Requirement The objective of this project is to validate a signal from the AHI that indicates the relative risk of warm-season cardio-respiratory mortality per unit concentration of ground-level ozone has substantially shifted in recent years. If verified, to explore possible explanations for this change. This work is supposed to provide information on the following questions:

(1) How to best manage missing ground ozone concentration data? (2) How to best link drug usage to the ozone’s adverse health effects? (3) How to best link demo-socio-econimic data to the ozone’s adverse health effects? (4) How to best model synthetically lagged ozone risk estimates at regional and national levels minimizing bias in risk estimates? (5) How to best model warm season health risk using (1)-(4)?

Estimated Value: The total amount of funds available for this contract is $55,000, plus applicable taxes. A seven-month contract will be awarded to the bidder who receives the highest technical score on their technical proposal and who can do the work within the proposed budget.

Ownership of Intellectual Property: The Contractor will own the Intellectual Property, while the Crown will have an irrevocable, royalty-free licence to use the IP.

Security Requirement: There is no security requirement.

Mandatory Requirements

M1. The bidder’s project leader must have a PhD from a recognized university with specialization in Statistics with experiences in public health, environment or epidemiologic studies.

M2. The bidder’s project leader must demonstrate that within the last 5 years, he/she has undertaken at least one project on Canadian health or clinical trials.

M3. The bidder’s project leader must have at least one peer-reviewed publication on statistical method development in scientific journals listed in the Science Citation Index Expanded (within the last 5 years).

M4. The bidder’s project leader must show that they have experience working with Canadian databases on drug, demographic and/or socio-economic status.

M5. The bidder’s project leader must have experience working with generalized additive models, generalized Poisson models and/or hierarchical models.

M6. The bidder’s project leader must show that they have experience working with statistical software such as R.

Selection Methodology The contract will be awarded to the bidder with the highest technical score who can commit to perform the work described in the Statement of Work for an amount not to exceed $55,000, taxes not included.

Enquiries regarding this Request for Proposals are to be submitted in writing to

Robert Merrick Contracting Authority E-mail: Robert.Merrick@hc-sc.gc.ca

Procurement

Category
Services
Jurisdiction
Federal

Not stated in the notice: procurement type, procurement method, selection criteria, region of delivery, region of opportunity, expected contract period, end user

Requirements and qualifications

Supply arrangement
Not stated in the public notice
Security requirement
Not stated in the public notice
Trade agreements
—
Limited tendering reason
—

Classification

GSIN
—
UNSPSC
—

Amendments

No amendments observed.

Documents

No attachments listed in the open data.

Contact

No contact listed in the open data.

Related

More from this buyer

No related records observed.

Linked contracts

No related records observed.

Source

Find on CanadaBuys

CanPursue has no direct link to this notice. This opens a CanadaBuys search for its solicitation number.

Source
CanadaBuys
Solicitation
1000173351
Observed
Sep 18, 2026

The amount, value range and contract duration shown on some CanadaBuys pages are not in the open data, so CanPursue does not show them.

Never miss an amendment

Track this opportunity in your pipeline and watchlists with a free account.

Create free account